Safety and Feasibility of Repeated Intrathecal Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells in Patients with Neurological Diseases

Table 1

Clinical characteristics of the patients at the time of enrolment.

Case number	Type of disease	Age (years)	Gender	Onset time (months)	Intrathecal frequency (times)	Follow-up time (months)
AD-001	AD	69	F	120	4	12
AD-002	AD	54	M	36	4	9
ADEM-003	ADEM	38	F	3	4	6
ES-004	ES	24	F	54	4	6
HSP-005	HSP	40	M	120	4	12
ICH-006	ICH	19	M	9	4	23
IS-007	IS	52	F	3	4	42
IS-008	IS	44	M	36	4	39
IS-009	IS	72	M	0.8	4	38
IS-010	IS	73	F	1.5	4	37
IS-011	IS	44	F	2	4	12
IS-012	IS	66	M	1	4	37
IS-013	IS	36	M	8	4	12
IS-014	IS	62	M	0.8	4	12
IS-015	IS	64	M	1	4	29
IS-016	IS	53	M	1	4	26
IS-017	IS	55	M	1	4	25
IS-018	IS	70	F	0.4	4	9
ML-019	ML	20	M	1	4	24
ML-020	ML	31	M	1.5	4	12
ML-021	ML	18	M	6	4	25
MND-022	FAS	75	F	24	4	11
MND-023	ALS	42	M	24	4	12
MND-024	SMA	58	M	48	4	35
MND-025	PBP	64	M	12	2	30
MND-026	ALS	70	M	24	4	12
MS-027	MS	58	F	48	4	26
MSA-028	MSA	60	M	12	4	37
MSA-029	MSA	53	F	19	4	12
SCA-030	SCA	55	F	12	4	39
SCA-031	SCA	57	F	60	4	25
SCI-032	SCI	25	M	1	4	38
SCI-033	SCI	53	M	2	4	37
SCI-034	SCI	61	M	12	4	18
SCI-035	SCI	30	M	6	4	8
TBI-036	PTBS	30	M	36	4	18
TP-037	TP	33	M	2	4	9

Abbreviations: AD, Alzheimer’s disease; ADEM, acute disseminated encephalomyelitis; ALS, amyotrophic lateral sclerosis; ES, encephalopathy syndrome; FAS, flail arm syndrome; HSP, hereditary spastic paraplegia; ICH, intracerebral haemorrhage; IS, ischaemia stroke; ML, myelitis; MND, motor neuron disease; MS, multiple sclerosis; MSA, multiple system atrophy; PBP, progressive bulbar paralysis; SCA, spinocerebellar ataxia; SCI, spinal cord injury; SMA, progressive spinal muscular atrophy; TBI, traumatic brain injury; TP, thermoplegia; M, male; F, female.